AssetMark Inc’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
AssetMark Inc's IRMD Position: Q1 2026 in Review
AssetMark Inc increased its iRadimed (IRMD) stake by 24% in Q1 2026, buying an estimated $900 and bringing the position to 47 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.
AssetMark Inc first reported a position in IRMD in Q1 2025 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- AssetMark Inc held 47 shares of iRadimed worth $4.52K as of Q1 2026.
- AssetMark Inc bought 9 iRadimed shares in Q1 2026, an estimated $900.
- iRadimed made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #2596 holding.
- AssetMark Inc first reported a position in iRadimed in Q1 2025 and has held it in 5 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.